Glutamate Modulator
Showing 1 - 25 of 639
Psychosis Trial in Albuquerque (Lumateperone, Risperidone)
Recruiting
- Psychosis
-
Albuquerque, New MexicoUniversity of New Mexico
May 25, 2023
Post Treatment Lyme Syndrome (PTLS), Chronic Pain Trial in New York (Milnacipran and D-cycloserine)
Terminated
- Post Treatment Lyme Syndrome
- +2 more
- Milnacipran with D-cycloserine augmentation
- Milnacipran with placebo augmentation
- (no location specified)
Sep 14, 2021
Magnetic Resonance Imaging, Major Depression, Alcoholism Trial in Iowa City (Ketamine, Alcohol Infusion)
Recruiting
- Magnetic Resonance Imaging
- +2 more
- Ketamine
- Alcohol Infusion
-
Iowa City, IowaUniversity of Iowa Health Care
Aug 25, 2022
Alcohol Use Disorder Trial in Charleston (Placebo, GET73)
Recruiting
- Alcohol Use Disorder
- Placebo
- GET73
-
Charleston, South CarolinaCharleston Alcohol Research Center, Institute of Psychiatry, Med
Jan 5, 2022
MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)
Completed
- Major Depressive Disorder
- +2 more
- AXS-05 (dextromethorphan and bupropion) oral tablets
-
Phoenix, Arizona
- +50 more
Sep 16, 2022
Depression, MDD Trial in United States (AXS-05, Placebo)
Completed
- Depression
- Major Depressive Disorder
- AXS-05
- Placebo
-
Phoenix, Arizona
- +42 more
Sep 22, 2021
Trichotillomania, Skin-Picking Trial in Chicago (Dronabinol, Placebo)
Completed
- Trichotillomania
- Skin-Picking
- Dronabinol
- Placebo
-
Chicago, IllinoisUniversity of Chicago
May 11, 2022
Borderline Personality Disorder Trial (Caplyta, Placebo)
Not yet recruiting
- Borderline Personality Disorder
- Caplyta
- Placebo
- (no location specified)
May 16, 2022
Effectiveness of CFTR Modulators According to Co-therapy
Not yet recruiting
- Cystic Fibrosis
- Discontinuation of respiratory co-therapy (azithromycin, RhDNase, or inhaled antibiotics)
- (no location specified)
Dec 15, 2022
Healthy Trial in Merksem (Adalimumab, Lipopolysaccharide (LPS))
Recruiting
- Healthy
- Adalimumab
- Lipopolysaccharide (LPS)
-
Merksem, BelgiumClinical Pharmacology Unit
May 22, 2023
Bipolar Depression, Suicidal Ideation Trial in New York (NRX-101, Lurasidone HCl, Placebo)
Completed
- Bipolar Depression
- Suicidal Ideation
- NRX-101
- +2 more
-
New York, New YorkNew York State Psychiatric Institute
Aug 5, 2022
Safinamide, Rasagiline and Other Standard of Care in PD
Recruiting
- Parkinson's Disease
-
Berlin, Germany
- +2 more
Aug 9, 2021
Longitudinal Effects of CFTR Modulator Drugs
Active, not recruiting
- Cystic Fibrosis
-
Denver, ColoradoNational Jewish Health
Sep 28, 2022
MDD, Treatment Resistant Depression, Bipolar Depression Trial in Rochester (Ketamine)
Enrolling by invitation
- Major Depressive Disorder
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Sep 12, 2022
Lung Carcinoma, Solitary Pulmonary Nodule, Cigarette Smoking Behavior Trial in Nashville (procedure, radiation, drug, other)
Completed
- Lung Carcinoma
- +2 more
- Computed Tomography
- +5 more
-
Nashville, Tennessee
- +1 more
Oct 17, 2022
Cocaine Use Disorder, Opioid Use Disorder Trial in Lexington (n-acetylcysteine, Hydromorphone, Placebo n-acetylcystine)
Recruiting
- Cocaine Use Disorder
- Opioid Use Disorder
- n-acetylcysteine
- +3 more
-
Lexington, Kentucky
- +1 more
Jan 17, 2023
Neurodegeneration in Multiple Sclerosis -Preclinical Study
Not yet recruiting
- Relapsing-Remitting Multiple Sclerosis (RRMS)
- +2 more
- Peripheral blood withdrawal
-
Pozzilli, Isernia, Italy
- +2 more
Feb 15, 2022
Healthy Trial in Charleston (Focused Ultrasound Stimulation)
Not yet recruiting
- Healthy
- Focused Ultrasound Stimulation
-
Charleston, South CarolinaMedical University of South Carolina
Mar 17, 2023
CFTR Modulators in Pregnant Individuals and in Postpartum
Not yet recruiting
- Cystic Fibrosis
- Pregnancy
-
Minneapolis, MinnesotaUniversity of Minnesota
Jan 6, 2023